Inactivated suckling mouse brain rabies vaccine provides short-term immunity in capuchin monkeys (Cebus apella)

Journal of Zoo and Wildlife Medicine

Volumn 32, Issue 1, 2001, Pages 55-57

  Passos, Estevão C ^a   Germano, Pedro M L ^b   Guimarães, Marcelo A B V ^c   Fedullo, José D L ^c   Corrêa, Sandra H R ^c   Consales, Cleide A ^a   Carrieri, Maria L ^a   Gonçalves, Margareth A ^d  

^a Instituto Pasteur de Sao Paulo   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c Fundacao Parque Zoologico de Sao Paulo   (Brazil)

^d Secretaria de Educação SP   (Brazil)

Author keywords

Capuchin monkey; Cebus apella; Neutralizing antibodies; Rabies; SMBV; Suckling mouse brain vaccine; Vaccination

Indexed keywords

ANIMALIA; CEBIDAE; CEBUS; CEBUS APELLA;

INACTIVATED VACCINE; RABIES VACCINE; VIRUS ANTIBODY;

ANIMAL; ANIMAL DISEASE; ARTICLE; BIOSYNTHESIS; BRAIN; CEBIDAE; FEMALE; IMMUNIZATION; IMMUNOLOGY; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; MONKEY DISEASE; MOUSE; RABIES; RABIES VIRUS; SUCKLING; TIME; ZOO ANIMAL;

ANIMALS; ANIMALS, SUCKLING; ANIMALS, ZOO; ANTIBODIES, VIRAL; BRAIN; CEBUS; FEMALE; IMMUNIZATION SCHEDULE; INJECTIONS, INTRAMUSCULAR; MALE; MICE; MONKEY DISEASES; RABIES; RABIES VACCINES; RABIES VIRUS; TIME FACTORS; VACCINES, INACTIVATED;

EID: 0042131899     PISSN: 10427260     EISSN: None     Source Type: Journal    
DOI: 10.1638/1042-7260(2001)032[0055:ISMBRV]2.0.CO;2     Document Type: Article

References (13)

1. Andrade, M. C. R., A. N. Oliveira, P. C. Romijn, and L. M. S. Kimura. 1999. Immune response produced by rabies vaccines in marmosets (Callitrichidae). Rev. Soc. Bras. Med. Trop. 32: 533-540.
2. Cabrera, M. A. A., M. J. Figueiredo, W. C. Silva, D. Ferrer, R. H. Teixeira, M. L. J. Cavalheiro, M. C. R. Andrade, R. C. Fernandes, and W. C. Moura. 1991. Antibody response to a inactivated rabies vaccine in some species of Brazilian monkeys. World Vet Congr. 24: 322. (Abstr.)
3. Favoretto, S. R., M. L. Carrieri, M. S. Tino, C. R. Zanetti, and O. A. C. Pereira. 1993. Simplified fluorescent inhibition microtest for the titration of rabies neutralizing antibodies. Rev. Inst. Med. Trop. São Paulo 35: 171-175.
4. Fuenzalida, E., and R. Palacios. 1955. An improved method for the preparation of rabies vaccine. Bol. Inst. Bacteriol. Chile 8: 3-10.
5. Gambeta, W. R., E. L. B. Chamelet, L. T. M. Souza, and M. P. Azevedo. 1979. Instituto Pasteur of São Paulo, a 75 Year Review (1903-1978): Historical Analyses of Technical and Scientific Actions in Rabies Prophylaxis. São Paulo, Instituto Pasteur/Coordenadoria de Serviços Técnicos Especializados da Secretaria de Estado da Saúde de São Paulo, São Paulo, Brazil. P. 37.
6. Germano, P. M. L., E. V. Silva, E. V. Silva, A. A. Preto, and C. F. Cordeiro. 1990. Evaluation of inactivated rabies vaccines in mice against antigenic relationships of rabies virus. Arq. Biol. Tecnol. 33: 551-560.
7. Habel, K. 1996. Habel test for potency. In: Meslin, F. X., M. M. Kaplan, and H. Koprowski (eds.). Laboratory Techniques in Rabies, 4th ed. World Health Organization, Geneva, Switzerland. Pp. 369-373.
8. Haigh, J. C., and M. F. Field. 1981. Rabies vaccination in a small zoo: antibody titers studies. J. Zoo Anim. Med. 12: 17-20.
9. Kessler, M. J., J. W. Summer, and G. M. Baer. 1982. Evaluation of killed rabies vaccine for rhesus monkeys (Macaca mulatta). J. Zoo Anim. Med. 13: 74-77.
10. Passos, J. J., I. B. Campello, M. J. Figueiredo, Z. Marmori, and C. S. P. Bastos. 1974. Rabies in wild animals. Resumos Congr. Bras. Med. Vet. 14: 103.
11. Piccinini, R. S., and C. E. A. Freitas. 1985. Experiences with rabies control in Brazil. In: Kuwert, E., C. Mérieux, H. Koprowski, and K. Bögel (eds.). Rabies in the Tropics. Springer-Verlag, Berlin, Germany. Pp. 737-741.
12. Sikes, R. K., W. F. Cleary, H. Koprowski, T. J. Wiktor, and M. M. Kaplan. 1971. Effective protection of monkeys against death from street virus by post-exposure administration of tissue-culture rabies vaccine. Bull. World Health Organ. 45: 1-11.
13. World Health Organization. 1992. WHO Expert Committee on Rabies, 8th Report. Technical Report Series 824. World Health Organization, Geneva, Switzerland. P. 84.